← Back to Search

MEG

Noninvasive Imaging for Epilepsy

N/A

Recruiting

Led By Sara K Inati, M.D.

Research Sponsored by National Institute of Neurological Disorders and Stroke (NINDS)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients aged 8 and older

Patients who had epilepsy surgery with presurgical evaluation under a specific protocol

Timeline

Screening 3 weeks

Treatment Varies

Follow Up all outcomes in this study are exploratory.

Awards & highlights

Study Summary

This trial will compare the sensitivities and specificities of morphometric analysis techniques using MRI images to pre- and postsurgical localization of epileptic foci in patients undergoing presurgical evaluation for medically refractory epilepsy, in order to establish an age-stratified normative imaging database.

Who is the study for?

This trial is for adults and children aged 8 or older with uncontrolled focal epilepsy, who are being evaluated for or have had epilepsy surgery. Participants must be able to consent themselves or through a guardian and cooperate with MRI scans without anesthesia.Check my eligibility

What is being tested?

The study aims to improve the detection of epileptic foci using MRI before and after surgery in patients with refractory epilepsy. It also involves creating a database from healthy volunteers for comparison, plus additional brain imaging (MEG) and cognitive testing.See study design

What are the potential side effects?

There are generally no direct side effects from participating in this trial as it involves noninvasive imaging techniques like MEG and MRI. However, some individuals might experience discomfort during scanning or claustrophobia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 8 years old or older.

Select...

I had epilepsy surgery after a detailed presurgical evaluation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ all outcomes in this study are exploratory.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~all outcomes in this study are exploratory.

This trial's timeline: 3 weeks for screening, Varies for treatment, and all outcomes in this study are exploratory. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

All outcomes in this study are Exploratory.

Trial Design

2Treatment groups

Experimental Treatment

Group I: healthy volunteersExperimental Treatment2 Interventions

healthy volunteers

Group II: PatientsExperimental Treatment2 Interventions

Patients

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MEG

2017

N/A

~1280

MRI

2009

Completed Phase 2

~1370

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Neurological Disorders and Stroke (NINDS)Lead Sponsor

1,340 Previous Clinical Trials

648,864 Total Patients Enrolled

77 Trials studying Epilepsy

24,453 Patients Enrolled for Epilepsy

Sara K Inati, M.D.Principal InvestigatorNational Institute of Neurological Disorders and Stroke (NINDS)

5 Previous Clinical Trials

2,376 Total Patients Enrolled

3 Trials studying Epilepsy

2,318 Patients Enrolled for Epilepsy

Media Library

MEG (MEG) Clinical Trial Eligibility Overview. Trial Name: NCT02107989 — N/A

Epilepsy Research Study Groups: healthy volunteers, Patients

Epilepsy Clinical Trial 2023: MEG Highlights & Side Effects. Trial Name: NCT02107989 — N/A

MEG (MEG) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02107989 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment actively looking for new participants?

"Per clinicaltrials.gov, this trial is actively enrolling participants; the protocol was first published on March 11th 2014 with a more recent update occurring September 27th 2022."

Answered by AI

What type of participant would be most suitable to join this investigation?

"To be considered for this trial, applicants must have aura and fall within the 8 to 65 age range. The total number of participants is estimated at 500 individuals."

Answered by AI

Is the eligibility for this clinical survey limited to individuals who are over 20 years of age?

"Patients that qualify for this medical trial must be between 8 and 65 years old. An additional 105 trials are currently recruiting patients younger than 18, while 161 clinical studies accept applicants over the age of 65."

Answered by AI

What is the current capacity for this medical experiment?

"Confirmed. As per the information available on clinicaltrials.gov, this medical trial is actively looking for participants and was initially posted in March of 2014. The study requires 500 patients to be recruited from two different research centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

2014. "Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02107989.

All > Focal Epilepsy > Paid Studies Maryland